Tocilizumab for Relapsing Polychondritis
This study has been withdrawn prior to enrollment.
(Tocilizumab was licenced in Canada for children, so the study was not necessary)
McMaster Children's Hospital
First Posted: April 15, 2010
Last Update Posted: May 13, 2014
Information provided by (Responsible Party):
Dr Maggie Larche, McMaster Children's Hospital